146 Results For "hepatitis"
 
Essential Hepatitis C medicine Sofosbuvir and Daclatasvir
Hepatitis C

Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug

MSF and others have filed an appeal against the European Patent Office’s decision to uphold US pharmaceutical corporation Gilead Science’s patent on the key hepatitis C drug sofosbuvir. Press Release - 5 Dec 2018
 
Out of Darkness- fighting Hepatitis C
Ukraine

"I am one of you: I live with HIV and used to live with hepatitis C"

Maksym*, a peer health educator working with MSF in Mykolaiv in the south of Ukraine, explains how he draws on his own experiences to connect with patients and make sure they complete their hepatitis C treatment successfully. Voices from the Field - 30 Nov 2018
 
Out of Darkness- fighting Hepatitis C
Ukraine

Mykolaiv project shows that hepatitis C can be effectively treated in people living with HIV

In Mykolaiv, in the south of Ukraine, MSF is taking an integrated approach to hepatitis C care for people living with HIV. The recent test results from patients who finished treatment since the start of the activities one year ago are extremely positive. Project Update - 30 Nov 2018
 
Am Timan Hospital, Chad - January 2017
Chad

MSF hands over medical programmes in Am Timan

Medecins Sans Frontieres (MSF) has completed the handover of its medical programmes in Am Timan, Salamat, Chad, to the Ministry of Public Health. Project Update - 20 Nov 2018
MSF protest against sofosbuvir patent in Munich
Hepatitis C

Médecins Sans Frontières (MSF) is gravely disappointed with the European Patent Office’s decision today to uphold US pharmaceutical corporation Gilead Sciences’ patent related to the key hepatitis C drug sofosbuvir. Access Campaign - 14 Sep 2018
 
Out of Darkness- fighting Hepatitis C
Hepatitis C

MSF calls for end to Gilead’s hepatitis C drug monopoly

This week in Munich, the European Patent Office is hearing a legal challenge filed by groups in 17 countries in March 2017, against an unmerited patent that allows US pharmaceutical corporation Gilead Sciences to charge exorbitant prices in Europe for the key hepatitis C drug sofosbuvir Press Release - 11 Sep 2018
 
Out of Darkness- fighting Hepatitis C
Ukraine

Out of Darkness: Fighting Hepatitis C in Ukraine

Millions of people in Ukraine continue to suffer silently through the pain of hepatitis C. Ukrainian photographer Aleksandr Glyadyelov spent several weeks in Mykolaiv with people living with hepatitis C, exploring their stories and the daily burden, suffering and hope of those affected by the disease. Photo Story - 27 Jul 2018
 
Key populations, peer-led HIV and SRH services
HIV/AIDS

Meeting the specific needs of key populations living with HIV

MSF’s experience in Mozambique, Malawi and India shows that if we do not respond to the specific health needs of key populations, we won’t be able to curb the HIV epidemic. Project Update - 23 Jul 2018
 
multi-antigenes vaccination campaign in CAR
Central African Republic

Protecting as many children as possible in an emergency context

MSF and the Ministry of Health complete a two-year multi-antigen mass vaccination campaign targeting about a quarter of all children under five in the Central African Republic. Project Update - 20 Jul 2018
 
Treating HIV and AIDS in Conakry
HIV/AIDS

MSF at AIDS 2018

Details of how to find info on MSF publications, materials, and sessions at the 22nd International AIDS Conference in Amsterdam, 23-27 July 2018. Follow on Twitter: @MSF_HIV Project Update - 16 Jul 2018
World Malaria Day 2018 in DRC
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more